Join us as we speak to Dr. Caron Jacobson, an Assistant Professor of Medicine at Harvard Medical School and a lymphoma physician and researcher at the Dana-Farber Cancer Institute. In this episode, Dr. Jacobson shares about the use and benefits of CAR T-cell therapy in B-cell cancers, such as diffuse large B-cell lymphoma (DLBCL), mantle cell lymphoma (MCL) and chronic lymphocytic leukemia (CLL). You will hear about how CAR T-cell therapy works, why it is used for B-cell cancers and the benefits of joining a clinical trial for this type of treatment.
Podcast: Play in new window | Download
Subscribe: Spotify | Pandora | Blubrry | Podchaser | More
CLICK HERE to participate in our episode survey.Mentioned on this episode:
- CAR T-cell Therapy
- Diffuse Large B-cell Lymphoma
- Mantle Cell Lymphoma
- Chronic Lymphocytic Leukemia
- Immune Effector Cell Therapy Program – Dana-Farber Cancer Institute
- Clinical Trial Support Center
Additional LLS Support Resources:
- Information Specialists
- Free telephone/web patient programs
- Free booklets
- Financial support – **Mantle Cell Lymphoma funding is OPEN**
- Online chats
- Caregiver support
- LLS Community
- Support groups
- Patti Robinson Kaufmann First Connection Program
- Free Nutrition Consultations
Support for this episode provided by Allogene; Bristol Myers Squibb; CRISPR Therapeutics; Kite, a Gilead Company; Janssen Oncology & Legend Biotech; and Novartis Pharmaceuticals.